GlassScriptPhysician profile
Jada Alston
NPI 1427692375
$17,770.79
in general payments reported to CMS, 2019-2025
36 companies · $4,590 in 2025
The $4,590 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,645 · 2022: $3,443 · 2023: $3,396 · 2024: $3,697 · 2025: $4,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,614.05 |
| Travel and Lodging | $1,069.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,251.40 | 2021-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $2,060.03 | 2021-2025 | Austedo Xr, Austedo, Uzedy |
| Abbvie INC. | $2,017.10 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,405.69 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $1,367.68 | 2021-2025 | Ingrezza |
| Brainsway USA INC | $1,076.85 | 2023-2025 | Deep Tms System |
| Vanda Pharmaceuticals INC. | $952.90 | 2021-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $892.62 | 2021-2025 | Rexulti, Abilify Asimtufii, Nuedexta |
| Lundbeck LLC | $838.89 | 2021-2025 | Rexulti |
| Alkermes, INC. | $766.56 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Supernus Pharmaceuticals, INC. | $746.19 | 2021-2025 | Qelbree, Qelbree |
| Axsome Therapeutics, INC. | $484.80 | 2022-2025 | Auvelity |
| Indivior INC. | $470.96 | 2022-2025 | Perseris, Sublocade |
| Bausch Health US, LLC | $358.57 | 2021-2025 | Aplenzin, Wellbutrin |
| Ironshore Pharmaceuticals INC. | $356.30 | 2022-2024 | Jornay Pm |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jada Alston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.